Pioneering innovation in the treatment of mitral and tricuspid regurgitation

Sponsored by Edwards Lifesciences

Anchorperson: J. Hausleiter

Spokesperson: V. Rudolph

Summary

This interventional session explores therapeutic strategies for mitral and tricuspid regurgitation, focusing on the clinical decision-making process between repair and replacement. Through two clinical cases, a 78-year-old male patient with severe degenerative mitral regurgitation and an 88-year-old female patient with atrial functional mitral regurgitation, experts review available transcatheter options and their procedural integration. The session features a presentation of several innovative devices, including the PASCAL Precision system, the EVOQUE system, and the SAPIEN M3 platform, highlighting their role in contemporary valve interventions.

Learning Objectives

To understand the decision-making process for transcatheter valve repair vs. replacement
To appreciate the key features of the PASCAL Precision system that help you navigate even challenging mitral or tricuspid anatomies
To learn from an educational LIVE case featuring the EVOQUE system to achieve tricuspid regurgitation resolution
To raise awareness of the latest innovation in mitral transcatheter approaches: the transseptal mitral valve replacement with SAPIEN M3 system

Speaker

V. Rudolph

To repair or to replace, that is the question